Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Issues Refusal-to-File Letter to Moderna
Published 3 months, 1 week ago
Description
In today’s Pharmaceutical Executive Daily, the FDA issues a refusal-to-file letter to Moderna for its seasonal influenza vaccine as the company secures a long-term agreement in Mexico, industry leaders assess China’s evolving role in global pharma strategy, and the FDA makes a decision on Keytruda in platinum-resistant ovarian cancer.